DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

MARK ASSET MANAGEMENT LP's Holding History (CIK: 0000860176)

Note: Option positions (PUT/CALL) are excluded.

Q4 2021

Shares 40,370 Value ($000) $1,801 Avg Close $47.38 Range $41.10 - $56.08

Q3 2021

Shares 20,529 Value ($000) $1,036 Avg Close $56.36 Range $47.02 - $79.50

Q2 2021

Shares 38,839 Value ($000) $3,047 Avg Close $61.86 Range $49.20 - $79.70

Q1 2021

Shares 111,919 Value ($000) $6,391 Avg Close $66.94 Range $52.23 - $84.25

Q4 2020

Shares 172,040 Value ($000) $14,410 Avg Close $60.45 Range $35.89 - $93.94

Q3 2020

Shares 179,429 Value ($000) $6,429 Avg Close $30.12 Range $22.36 - $39.22

Q2 2020

Shares 180,498 Value ($000) $4,364 Avg Close $23.51 Range $15.72 - $29.39

Q1 2020

Shares 162,522 Value ($000) $2,846 Avg Close $20.86 Range $12.39 - $30.41

Q4 2019

Shares 66,557 Value ($000) $1,159 Avg Close $16.65 Range $14.24 - $20.17

Q3 2019

Shares 68,864 Value ($000) $1,055 Avg Close $19.11 Range $15.29 - $22.26

Q2 2019

Shares 70,532 Value ($000) $1,464 Avg Close $22.41 Range $18.28 - $28.86

Q1 2019

Shares 70,532 Value ($000) $1,638 Avg Close $20.92 Range $17.73 - $25.05

Q4 2018

Shares 19,900 Value ($000) $411 Avg Close $18.14 Range $13.78 - $22.40

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2021	40,370	$1,801	$47.38	$41.10 - $56.08
Q3 2021	20,529	$1,036	$56.36	$47.02 - $79.50
Q2 2021	38,839	$3,047	$61.86	$49.20 - $79.70
Q1 2021	111,919	$6,391	$66.94	$52.23 - $84.25
Q4 2020	172,040	$14,410	$60.45	$35.89 - $93.94
Q3 2020	179,429	$6,429	$30.12	$22.36 - $39.22
Q2 2020	180,498	$4,364	$23.51	$15.72 - $29.39
Q1 2020	162,522	$2,846	$20.86	$12.39 - $30.41
Q4 2019	66,557	$1,159	$16.65	$14.24 - $20.17
Q3 2019	68,864	$1,055	$19.11	$15.29 - $22.26
Q2 2019	70,532	$1,464	$22.41	$18.28 - $28.86
Q1 2019	70,532	$1,638	$20.92	$17.73 - $25.05
Q4 2018	19,900	$411	$18.14	$13.78 - $22.40